Verteporfin therapy and triamcinolone acetonide: convergent modes of action for treatment of neovascular age-related macular degeneration. (Q36693401)
Jump to navigation
Jump to search
scientific article published on November 2006
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Verteporfin therapy and triamcinolone acetonide: convergent modes of action for treatment of neovascular age-related macular degeneration. |
scientific article published on November 2006 |
Statements
Verteporfin therapy and triamcinolone acetonide: convergent modes of action for treatment of neovascular age-related macular degeneration (English)
U Schmidt-Erfurth
1 November 2006